About John Thomas, Jr.
Form D filings for Nexsis Biosciences in 2024 list John Thomas, Jr. as chief financial officer.
John Thomas, Jr. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Thomas, Jr. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Thomas, Jr. works with at each company, as listed on that company's latest Form D.
Nexsis Biosciences LLC · Form D, Jun 24, 2024
BL
Beecher Lewis
Executive officer and director
SC
Scott Cart
Executive officer and director
JP
John Pirris
Director